These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2960392)

  • 21. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on T cell subsets responsible for syngeneic mixed lymphocyte reaction].
    Aranami T
    Hokkaido Igaku Zasshi; 2000 Sep; 75(5):315-24. PubMed ID: 11070792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of in vitro cytotoxic T lymphocyte generation. III. Interactions or regulatory T cell subsets in suppressor and target populations.
    Schwartz A; Gershon RK
    J Mol Cell Immunol; 1984; 1(4):237-52. PubMed ID: 6152894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Polyamine metabolism in isoproterenol-stimulated mouse salivary glands].
    Tanioka H; Shiba K; Inoue H; Kato Y; Asada A
    Osaka Daigaku Shigaku Zasshi; 1974 Jun; 19(1):113-21. PubMed ID: 4530083
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on naïve CD4+CD25+T cells inhibition of naïve CD4+CD25- T cells in mixed lymphocyte cultures.
    Hall BM; Robinson CM; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ
    Transpl Immunol; 2008 Feb; 18(4):291-301. PubMed ID: 18158114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytes.
    Finkelman FD; Malek TR; Shevach EM; Mond JJ
    J Immunol; 1986 Oct; 137(7):2252-9. PubMed ID: 3093569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allospecific suppression without requirement for participation of Ly 2+ cells.
    Holán V; Mitchison NA
    Immunology; 1984 Mar; 51(3):469-75. PubMed ID: 6199292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production.
    Macatonia SE; Doherty TM; Knight SC; O'Garra A
    J Immunol; 1993 May; 150(9):3755-65. PubMed ID: 8097224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of irradiation on isoproterenol-stimulated cell-proliferation in the salivary glands (author's transl)].
    Winter WA
    Verh Dtsch Ges Pathol; 1972; 56():472-6. PubMed ID: 4130872
    [No Abstract]   [Full Text] [Related]  

  • 32. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation of mouse T-cell lymphoma lines from different long-term interleukin 2-dependent cultures.
    Giglia JS; Ovak GM; Yoshida MA; Twist CJ; Jeffery AR; Pauly JL
    Cancer Res; 1985 Oct; 45(10):5027-34. PubMed ID: 3875403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of trichostatin A on proliferation and interleukin-2 expression of mouse T cells in mixed lymphocyte culture].
    Wei Q; Yu LX; Deng WF; Ye JS
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):467-9. PubMed ID: 18359716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.
    O'Neill HC; Ni K
    Immunology; 1993 Jun; 79(2):220-8. PubMed ID: 8344701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of thymocytes in fetal organ culture: analysis of phenotypic changes accompanying the appearance of cytolytic and interleukin 2-producing cells.
    Kisielow P; Leiserson W; Von Boehmer H
    J Immunol; 1984 Sep; 133(3):1117-23. PubMed ID: 6611365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Existence of T cells manifesting self-reactivity indistinguishable from alloreactivity.
    Altman A; Katz DH
    J Immunol; 1980 Oct; 125(4):1536-43. PubMed ID: 6157739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 10 is a human T cell growth factor in vitro.
    Pawelec G; Pohla H; Schlotz E; Rehbein A; Schaudt K; Hambrecht A; Friccius H
    Cytokine; 1995 May; 7(4):355-63. PubMed ID: 8589266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ia antigen-stimulated proliferation and IL-2 production in the syngeneic mixed lymphocyte reaction.
    Lattime EC; Golub SH; Gillis S; Pecoraro GA; Stutman O
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1055-6. PubMed ID: 6455814
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses.
    Malek TR; Robb RJ; Shevach EM
    J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.